SCHEMBL31240493

SCHEMBL31240493

Nc1n[nH]c2ccc(-c3ccnc(NC(=O)Cc4ccccc4)c3)cc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ WNT3A P56704 1/20 0.57
▸ MEN1 O00255 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ RAB9A P51151 1/20 0.52
▸ JAK2 O60674 2/20 0.51
▸ F11 P03951 1/20 0.49
▸ RIOK2 Q9BVS4 1/20 0.49
▸ TTK P33981 1/20 0.48
▸ WNT1 P04628 2/20 0.48
▸ SLC6A2 P23975 1/20 0.48
▸ SLC6A3 Q01959 1/20 0.48
▸ MAPK14 Q16539 2/20 0.48
▸ NPY5R Q15761 1/20 0.47
▸ CCKBR P32239 1/20 0.47
▸ CLK2 P49760 1/20 0.47
▸ CLK3 P49761 1/20 0.47
▸ DYRK1A Q13627 1/20 0.47
▸ CDK2 P24941 4/20 0.47
▸ GSK3B P49841 1/20 0.47
▸ CDK1 P06493 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31240509 0.92 JAK2 (0.56) WNT3AMEN1KMT2ARAB9AJAK2
SCHEMBL31240675 0.92 WNT3A (0.52) WNT3AMEN1KMT2ARAB9AJAK2
SCHEMBL31240445 0.91 WNT3A (0.47) WNT3AMEN1KMT2ARAB9AJAK2
SCHEMBL31240563 0.90 DYRK1A (0.51) WNT3AJAK2WNT1CLK2CLK3
SCHEMBL31240349 0.90 WNT3A (0.50) WNT3AMEN1KMT2ARAB9AJAK2
SCHEMBL31240714 0.90 WNT3A (0.55) WNT3AMEN1KMT2ARAB9AJAK2
SCHEMBL31240507 0.90 TTK (0.50) WNT3ARAB9AJAK2F11TTK
SCHEMBL31240240 0.90 MAPK14 (0.55) WNT3AMEN1KMT2ARAB9AJAK2
SCHEMBL31240382 0.89 MAPK1 (0.52) WNT3AMAPK14CLK2CLK3DYRK1A
SCHEMBL31240399 0.89 JAK2 (0.54) WNT3AJAK2F11RIOK2NPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP claimed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO claimed
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP disclosed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO disclosed
Send feedback